{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:36:21Z","timestamp":1793730981682,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010801","name":"Government of Galicia","doi-asserted-by":"publisher","award":["ED481A 2022\/237"],"award-info":[{"award-number":["ED481A 2022\/237"]}],"id":[{"id":"10.13039\/501100010801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ED431G 2019\/02"],"award-info":[{"award-number":["ED431G 2019\/02"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FJC2021-047282-I"],"award-info":[{"award-number":["FJC2021-047282-I"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ED481A 2022\/237"],"award-info":[{"award-number":["ED481A 2022\/237"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ED481A - 2024-203"],"award-info":[{"award-number":["ED481A - 2024-203"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020636","name":"Spain Ministry of Education Vocational Training and Sports","doi-asserted-by":"publisher","award":["FPU22\/02155"],"award-info":[{"award-number":["FPU22\/02155"]}],"id":[{"id":"10.13039\/501100020636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008425","name":"Government of Galicia Department of Education Science Universities and Professional Training","doi-asserted-by":"publisher","award":["ED431C 2021\/17"],"award-info":[{"award-number":["ED431C 2021\/17"]}],"id":[{"id":"10.13039\/501100008425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["CNS2022-135365"],"award-info":[{"award-number":["CNS2022-135365"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2021-122780OB-I00"],"award-info":[{"award-number":["PID2021-122780OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["FJC2021-047282-I"],"award-info":[{"award-number":["FJC2021-047282-I"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114455","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:53:16Z","timestamp":1763765596000},"page":"114455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Nanoassemblies for oral protein delivery \u2014 The case of monoclonals for inflammatory bowel disease"],"prefix":"10.1016","volume":"389","author":[{"given":"Ana M.","family":"L\u00f3pez-Est\u00e9vez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda G.","family":"Portela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pi\u00f1eiro-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Castillo-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Sancho-Temi\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"G\u00f3mez-Lado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Codesido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurxo","family":"Garc\u00eda-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Medel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Fern\u00e1ndez-Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Fern\u00e1ndez-Ace\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00e1nzazu","family":"Cruz-Adalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114455_bb0005","author":"The Antibody Society"},{"key":"10.1016\/j.jconrel.2025.114455_bb0010","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114455_bb0015","article-title":"Personalized Cancer nanomedicine: overcoming biological barriers for intracellular delivery of biopharmaceuticals","author":"L\u00f3pez-Est\u00e9vez","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114455_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114455_bb0025","author":"US Food and Drug Administration"},{"key":"10.1016\/j.jconrel.2025.114455_bb0030","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s11154-022-09735-8","article-title":"A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes","volume":"23","author":"Aroda","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.jconrel.2025.114455_bb0035","article-title":"NEORAL \u00ae soft gelatin capsules (cyclosporine capsules, USP) MODIFIED NEORAL \u00ae Oral solution (cyclosporine oral solution, USP)","author":"US Food and Drug Administration","year":"2025","journal-title":"Modified"},{"key":"10.1016\/j.jconrel.2025.114455_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106379","article-title":"Oral infliximab nanomedicines for targeted treatment of inflammatory bowel diseases","volume":"183","author":"Mohan","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114455_bb0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.actbio.2021.12.015","article-title":"Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease","volume":"140","author":"Shrestha","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114455_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-020-00693-4","article-title":"Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model","volume":"18","author":"Kim","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114455_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118556","article-title":"Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease","volume":"273","author":"Li","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2025.114455_bb0060","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/j.gastro.2012.06.043","article-title":"An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice","volume":"143","author":"Vong","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.114455_bb0065","first-page":"1","article-title":"Oral delivery of biologics in inflammatory bowel disease treatment","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114455_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.110880","article-title":"Effect of particle size on the cellular uptake and anti-inflammatory activity of oral nanotherapeutics","volume":"187","author":"Zhou","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.114455_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2023.102848","article-title":"Surface design of nanocarriers: key to more efficient oral drug delivery systems","volume":"313","author":"Spleis","year":"2023","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2025.114455_bb0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114455_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109861","article-title":"Non-small cell lung cancer combination therapy: hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab","volume":"125","author":"Pang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.114455_bb0090","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1039\/D0BM00556H","article-title":"Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells","volume":"8","author":"Bai\u00e3o","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114455_bb0095","doi-asserted-by":"crossref","DOI":"10.1007\/s12274-024-6826-8","article-title":"Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery \u2013 design, characterization, and biological insights","author":"L\u00f3pez-Est\u00e9vez","year":"2024","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2025.114455_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jconrel.2024.07.032","article-title":"Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors","volume":"373","author":"L\u00f3pez-Est\u00e9vez","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114455_bb0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s13346-019-00678-3","article-title":"Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes","volume":"10","author":"Samaridou","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114455_bb0110","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.1021\/acsnano.2c04330","article-title":"Barriers to the intestinal absorption of four insulin-loaded arginine-rich nanoparticles in human and rat","volume":"16","author":"Lundquist","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114455_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2017.01.066","article-title":"Potential of single cationic amino acid molecule \u201carginine\u201d for stimulating oral absorption of insulin","volume":"521","author":"Kamei","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114455_bb0120","doi-asserted-by":"crossref","first-page":"34097","DOI":"10.1039\/D3RA06647A","article-title":"Structural modulation of insulin by hydrophobic and hydrophilic molecules","volume":"13","author":"Begum","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2025.114455_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2018.03.004","article-title":"PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy","volume":"276","author":"Niu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114455_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030747","article-title":"Exploring the pipeline of novel therapies for inflammatory bowel disease; state of the art review","volume":"11","author":"Zurba","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2025.114455_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002121","article-title":"Polymer conjugation of docosahexaenoic acid potentiates Cardioprotective therapy in preclinical models of myocardial ischemia\/reperfusion injury","volume":"10","author":"Tejedor","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114455_bb0140","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.4c09823","article-title":"Biodistribution of 89 Zr-radiolabeled Nanoassemblies for monoclonal antibody delivery revealed through in vivo PET imaging","author":"L\u00f3pez-Est\u00e9vez","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2025.114455_bb0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2017.02.024","article-title":"Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers","volume":"263","author":"Niu","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114455_bb0150","series-title":"Hapten-Induced Model of Chronic Inflammation and Ulceration in the Colon Rat","author":"Morris","year":"2025"},{"key":"10.1016\/j.jconrel.2025.114455_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijpharm.2018.08.005","article-title":"Longitudinal PET\/CT evaluation of TNBS-induced inflammatory bowel disease rat model","volume":"549","author":"Seoane-Via\u00f1o","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114455_bb0160","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.7150\/thno.47601","article-title":"Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114455_bb0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2020.10.007","article-title":"Therapeutic potential of polypeptide-based conjugates: rational design and analytical tools that can boost clinical translation","volume":"160","author":"Melnyk","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114455_bb0170","doi-asserted-by":"crossref","first-page":"12675","DOI":"10.1073\/pnas.1710408114","article-title":"Selective killing of helicobacter pylori with pH-responsive helix\u2013coil conformation transitionable antimicrobial polypeptides","volume":"114","author":"Xiong","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114455_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.114455_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114455_bb0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114455_bb0190","article-title":"Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: application to bevacizumab","author":"Pangua","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114455_bb0195","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1021\/acsnano.2c09266","article-title":"Oral delivery of therapeutic antibodies with a transmucosal polymeric carrier","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114455_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.136438","article-title":"Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease","volume":"445","author":"Li","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2025.114455_bb0205","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nprot.2010.13","article-title":"Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine","volume":"5","author":"Vosjan","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2025.114455_bb0210","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.actbio.2021.12.015","article-title":"Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease","volume":"140","author":"Shrestha","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114455_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-020-00165-3","article-title":"Hydrogen peroxide and disease: towards a unified system of pathogenesis and therapeutics","volume":"26","author":"Pravda","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114455_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900610","article-title":"A Proresolving peptide Nanotherapy for site-specific treatment of inflammatory bowel disease by regulating Proinflammatory microenvironment and gut microbiota","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114455_bb0225","doi-asserted-by":"crossref","DOI":"10.1021\/acs.analchem.4c01882","article-title":"Analysis of the structure of 14 therapeutic antibodies using circular dichroism spectroscopy","author":"Bruque","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2025.114455_bb0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/19420862.2018.1530920","article-title":"Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumab","volume":"11","author":"Lee","year":"2019","journal-title":"MAbs"},{"key":"10.1016\/j.jconrel.2025.114455_bb0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2022.11.032","article-title":"Insulin-loaded liposomes packaged in alginate hydrogels promote the oral bioavailability of insulin","volume":"353","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114455_bb0240","article-title":"pH-responsive and Mucoadhesive nanoparticles for enhanced Oral insulin delivery: the effect of hyaluronic acid with different molecular weights","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114455_bb0245","doi-asserted-by":"crossref","first-page":"45651","DOI":"10.1021\/acsami.3c09866","article-title":"Rationally designed Naringenin-conjugated polyester nanoparticles enable folate receptor-mediated Peroral delivery of insulin","volume":"15","author":"Heyns","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114455_bb0250","doi-asserted-by":"crossref","first-page":"33491","DOI":"10.1021\/acsami.3c07124","article-title":"Net-neutral nanoparticles-extruded microcapsules for Oral delivery of insulin","volume":"15","author":"Lu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114455_bb0255","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/1061186X.2015.1086359","article-title":"Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids","volume":"23","author":"Yildiz","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2025.114455_bb0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2016.07.051","article-title":"Role of nanoparticle size, shape and surface chemistry in oral drug delivery","volume":"238","author":"Banerjee","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114455_bb0265","article-title":"Radiopharmaceuticals and their applications in medicine","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114455_bb0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2016.02.014","article-title":"Gastrointestinal stability of therapeutic anti-TNF \u03b1 IgG1 monoclonal antibodies","volume":"502","author":"Yadav","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114455_bb0275","series-title":"Anatomical and Physiological Parameters a Ecting Gastrointestinal Absorption in Humans and Rats","volume":"39","author":"Desesso","year":"2001"},{"key":"10.1016\/j.jconrel.2025.114455_bb0280","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0927-7765(99)00157-5","article-title":"The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration","volume":"18","author":"Tob\u00edo","year":"2000","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2025.114455_bb0285","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-021-00770-2","article-title":"Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics","volume":"19","author":"Guo","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114455_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125011","article-title":"PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model","volume":"669","author":"Codesido","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114455_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122261","article-title":"PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model","volume":"627","author":"Garc\u00eda-Otero","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114455_bb0300","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1053\/j.gastro.2021.08.045","article-title":"PTG-100, an Oral \u03b14\u03b27 antagonist peptide: preclinical development and phase 1 and 2a studies in ulcerative colitis","volume":"161","author":"Sandborn","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.114455_bb0305","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ibd.20753","article-title":"Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis","volume":"15","author":"Alex","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2025.114455_bb0310","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.3748\/wjg.v20.i48.18177","article-title":"Role of interleukin-22 in inflammatory bowel disease","volume":"20","author":"Li","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2025.114455_bb0315","doi-asserted-by":"crossref","first-page":"II3","DOI":"10.1093\/ecco-jcc\/jjac034","article-title":"Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention","volume":"16","author":"Sewell","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.jconrel.2025.114455_bb0320","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2017.12.023","article-title":"Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronate","volume":"271","author":"Rajan","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114455_bb0325","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jconrel.2024.08.023","article-title":"An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease","volume":"374","author":"Zhang","year":"2024","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:54:37Z","timestamp":1781326477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925010697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":65,"alternative-id":["S0168365925010697"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114455","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoassemblies for oral protein delivery \u2014 The case of monoclonals for inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114455"}}